Gut Dysbiosis and Thrombosis: Rethinking Chronic GI Symptoms Through a Vascular Lens

There is a familiar patient in naturopathic and integrative medicine practice: The one with chronic bloating, dysregulated satiety, postprandial and other GI discomfort, alternating stool patterns, food reactivity, fatigue, and related concerns. They could be post-viral, dealing with chronic infections, mold-sensitive, autoimmune, or all of the above. Many have had endoscopy, imaging, stool work, elimination diets, antimicrobials, probiotics, enzymes, detox, and still the lingering symptoms do not fully resolve. 

What if part of the problem is not primarily toxin-related, infectious, or even immunologic, but hemodynamic?  

A growing body of research is beginning to reshape how practitioners may think about the relationship between the gut microbiome and systemic illness—particularly in the realm of coagulation and vascular health. 

A 2024 study in Thrombosis Research adds important momentum to this shift (1). In this study, investigators identified significant alterations in both gut microbiota composition and serum metabolomic profiles in patients with venous thromboembolism (VTE). Their findings suggest that thrombotic disease is not purely vascular—but may be, at least in part, microbiome-mediated. 

Key Points 

An important insight from this body of research is not simply that dysbiosis is present in VTE—it is that dysbiosis may play a driving role in issues related to circulation and hypercoagulation, creating a vicious cycle that can have systemic impacts.  

As scientists and clinicians are increasingly observing, the gut microbiome can directly influence thrombin generation, platelet activity, and endothelial function. 

Other data has demonstrated that altering the gut microbiome via fecal microbiota transplantation could directly change thrombin generation parameters in humans, providing important insights linking gut ecology to coagulation (2).

A Bidirectional Loop 

Taken together, these findings support a bidirectional model: 

• Dysbiosis produces metabolites that promote systemic inflammation and pro-thrombotic signaling
• Increased coagulation and endothelial dysfunction impair microvascular perfusion
• Reduced perfusion compromises gut barrier integrity
• Barrier breakdown further worsens dysbiosis and endotoxemia 

This creates a self-reinforcing loop between the gut and the vascular system. 

As many functional providers are aware, these patients often have standard gastrointestinal workups that are unrevealing, or lead to more questions than answers.  

This emerging data opens the door to more integrated strategies—where addressing circulation along with microbiome composition, intestinal permeability, inflammatory signaling, and other aspects, can have important benefits for those with complex GI symptoms and concerns.